

COVID-19: Lessons from pediatric science and practice
https://doi.org/10.21508/1027-4065-2022-67-2-142-152
Abstract
The pandemic of a new severe infection, announced by the World Health Organization last year, is still spreading. To a certain extent, the epidemic has affected the pediatric population. Children have not been left out of the spread of COVID-19, and this applies even to newborns. The lecture presents summary data on the results of clinical observations both in the Tushino Children’s City Clinical Hospital in Moscow and scientific sources. A new disease is really new. This applies to its pathogenesis, diagnosis, treatment tactics with the use of modern medicines. For the first time, pediatricians are faced with the incredible situation where adults are more severely affected than children. It was noted that due to the limited period and scarce observations, all recommendations existing at this stage are temporary and undoubtedly subject to clarification. Most information regarding the impact of COVID-19 on a child is in clinical trials and is en route to be introduced into pediatric practice.
About the Authors
L. A. KharitonovaRussian Federation
Moscow
K. I. Grigoriev
Russian Federation
Moscow
References
1. Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181: 271–280. DOI: 10,1016/j.cell.2020.02.052
2. Synowiec A., Szczepanski A., Barreto-Duran E., Lie L.K., Pyrc K. Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): a systemic infection. Clin Microbiol Rev 2021; 34: e00133–20. DOI: 10,1128/CMR.00133–20
3. Logunov D.Y., Dolzhikova I.V., Shcheblyakov D.V., Tukhvatulin A.I., Zubkova O.V., Dzharullaeva A.S. et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet 2021; 397(10275): 671–681. DOI: 10,1016/S0140–6736(21)00234–8
4. Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses 2019; 11(1): 59. DOI: 10,3390/v11010059
5. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Сlinical features of patients infected with the new coronavirus 2019 in Wuhan, China. The Lancet 2020; 395: 497–506
6. Mallapaty S. Why does the coronavirus spread so easily between people? Nature 2020; 579: 183. DOI: 10,1038/d41586–020–00660-x
7. Rumyantsev A.G. Coronavirus infection COVID-19. Scientific challenges and possible ways of treatment and prevention of the disease. Rossiyskiy zhurnal detskoy gematologii i onkologii 2020; 7(3): 47–53. (in Russ.) DOI: 10,21682/2311–1267–2020–7–3–47–53
8. Aksenova A.Yu. Von Willebrand factor and endothelial damage: a possible link to COVID-19. Ecological genetics. 2020; 18(2): 135–138. (in Russ.) DOI: 10,17816/ecogen33973
9. Liu J., Li S., Liu J., Liang B., Wang X., Wang H. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBio- Medicine 2020; 55: 102763. DOI: 10,1016/j.ebiom.2020,102763
10. Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F. et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med 2020; 383(4): 334–346. DOI: 10,1056/NEJMoa2021680
11. Liang W., Feng Z., Rao S., Xiao C., Xue X., Lin Z. et al. Diarrhea may be underestimated: the missing link in the new coronavirus 2019. Gut 2020; 69: 1141–1143. DOI: 10,1136/gutjnl-2020–320832
12. Salvatore S., Marinoni M., Agosti М. Additional Concerns Regarding Children With Coronavirus Disease 2019. JAMA Pediatr 2020; 174(12): 1217–1218. DOI: 10,1001/jamapediatrics.2020,2922
13. Levin M. Childhood Multisystem Inflammatory Syndrome — A New Challenge in the Pandemic. N Engl J Med 2020; 383(4): 393–395. DOI: 10,1056/NEJMe2023158
14. Onouchi Y. The genetics of Kawasaki disease. Int J Rheum Dis 2018; 21: 26–30. DOI: 10,1111/1756–185X.13218
15. Namazova-Baranova L.S. Coronavirus infection (COVID-19) in children. Pediatricheskaya farmakologiya 2020; 17 (3): 162–168. (in Russ.) DOI:10,15690/pf.v17i3,2121)
16. Lassandro G., Palladino V., Amoruso A., Palmieri V.V., Russo G., Giordano P. Children in Coronaviruses Wonderland: What Clinicians Need to Know. Mediterr J Hematol Infect Dis 2020; 12(1): e2020042. DOI: 10,4084/MJHID.2020,042
17. Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z. et al. Sars-Cov-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382 (12): 1177–1179. DOI: 10,1056/NEJMc2001737
18. an Doremalen N., Bushmaker T., Morris D.H., Holbrook M.G., Gamble A., Williamson B.N., Tamin A. et al. Aerosol and surface stability of Sars-Cov-2 as compared with Sars-Cov-1. N Engl J Med 2020; 382(16): 1564–1567. DOI: 10,1056/NEJMc2004973
19. Namazova-Baranova L.S., Baranov A.A. COVID-19 and children. Pulmonologiya 2020; 30(5): 609–628. (in Russ.) DOI: 10,18093/0869–0189–2020–30–5–609–628
20. Jiehao C., Jin X., Daojiong L., Zhi Y., Lei X., Zhenghai Q. et al. A case series of children with 2019 novel coronavirus infection: Clinical and epidemiological features. Clin Infect Dis 2020; 71(6): 1547–1551. DOI: 10,1093/cid/ciaa198
21. Donà D., Minotti C., Costenaro P., Da Dalt L., Giaquinto C. Fecal-Oral Transmission of SARS-CoV-2 In Children: is it Time to Change Our Approach? Pediatr Infect Dis J 2020; 39 (7): e133–e134. DOI: 10,1097/INF.0000000000002704
22. Gorelov A.V., Nikolaeva S.V., Akimkin V.G. New coronavirus infection COVID-19: features of the course in children in the Russian Federation. Pediatriya. Zhurnal of Speranskyi 2020; 99 (6): 57–62. (in Russ.)
23. Meskina E.R. Preliminary clinical and epidemiological analysis of the first 1000 cases of COVID-19 in children in the Moscow region. Zhurnal mikrobiologii, epidemiologii i immunobiologii 2020; 97(3): 202–215. (in Russ.) DOI: 10,36233/0372–9311–2020–97–3–2
24. De Rose D.U., Piersigilli F., Ronchetti M.P., Santisi А., Bersani Il., Dotta A. et al. Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far. Italian J Pediatr 2020; 46: 56–64. DOI: 10,1186/s13052–020–0820-x
25. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395(10229): 1054–1062. DOI: 10,1016/S0140–6736(20)30566–3
26. Interim guidelines for the prevention, diagnosis and treatment of novel coronavirus infection (COVID-19). Version 8 (03.09.2020). Ministry of Health of the Russian Federation, 2020: 220. (in Russ.) https://стопкоронавирус.рф/ai/doc/1213/attach/vmr_COVID-19_V14_27–12–2021.pdf/ Ссылка активна на 28.02.2022.
27. Zhu H., Wang L., Fang C., Peng S., Zhang L., Chang G. et al. Clinical analysis of 10 neonates born to mothers with 2019- nCoV pneumonia. Transl Pediatr 2020; 9(1): 51–60. DOI: 10,21037/tp.2020.02.06
28. Pimanov S.I., Dikareva E.A. Gastroenterological manifestations of COVID-19: first generalizations. Klinicheskiy razbor v obshchey meditsine 2020; 1: 6–13. (in Russ.) DOI: 10,47407/kr2020,1.1,00001
29. Furman E.G. Coronavirus infection COVID-19 and children. Pediatriya. Zhurnal of Speranskyi 2020; 99(3): 245–251. (in Russ.)
30. Gomi R., Asgari N., Hajiheidari A., Esteki R., Baybanaki F., Nasirinasab F. The COVID-19 pandemic: a systematic review of current evidence. Infektsiya i immunitet 2020; 10(4): 655–663. (in Russ.) DOI: 10,15789/2220–7619-TCP-1508
31. Kaleda M.I., Nikishina I.P., Fedorov E.S., Nasonov E.L. Coronavirus Disease 2019 (COVID-19) in Children: Lessons from Pediatric Rheumatology. Nauchno-prakticheskaya revmatologiya 2020; 58 (5): 469–479. (in Russ.) DOI: 10,47360/1995–4484–2020–469–479
32. Whittaker E., Bamford A., Kenny J., Kaforou M., Joneset C.E., Shah P. et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324(3): 259–269. DOI: 10,1001/jama.2020,10369
33. Belhadjer Z., Méot M., Bajolle F., Khraichet D., Legendre A., Abakka S. et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation 2020; 142(5): 429–436. DOI: 10,1161/CIRCULATIONAHA.120,048360
34. Multisystem Inflammatory Syndrome in Children (MIS-C). Centers for Disease Control and Prevention [internet]. https://www.cdc.gov/mis-c/hcp/ Ссылка активна на 25.02.2022
35. Azkur Ah. K., Akdis M., Azkur D., Sokolowska М., van de Veen W., Brüggen M.-Ch., еt al. Immune response to SARSCoV- 2 and mechanisms of immunopathological changes in COVID-19. Allergy 2020; 75(7): 1564–1581. DOI: 10,1111/all.14364
36. Deeks J.J., Dinnes J., Takwoingi Y., Davenport C., Spijker R., Taylor-Phillips S. et al. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev 2020; 6(6): CD013652. DOI: 10,1002/14651858.CD013652
37. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020:1–10. DOI: 10,1016/S0140–6736(20)30183–5
38. Zaplatnikov A.L., Osmanov I.M., Gorev V.V., Dmitriev A.V., Mironova A.K., Dementyev A.A. et al. New coronavirus infection COVID-19 in the practice of a neonatologist and pediatrician. Rossiyskiy vestnik perinatologii i pediatrii 2020; 65(3): 11–17. (in Russ.) DOI: 10,21508/1027–4065–2020–65–3–11–17
39. Pilat T.L., Radysh I.V., Surovtsev V.V., Korosteleva M.M., Khanferyan R.A. Possibilities of specialized dietary correction of disorders of the gastrointestinal tract in patients with COVID-19 viral infection. Lechashchiy vrach 2020; 8: 11– 18. (in Russ.)
40. Сао В., Wang Y., Wen D., Liu W., Wang J., Fan G. et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med 2020; 382(19): 1787–1799. DOI: 10,1056/NEJMoa2001282
41. Melekhina E.V., Gorelov A.V., Music A.D. Clinical features of the course of COVID-19 in children of different age groups. Literature review by early April 2020. Voprosy prakticheskoy pediatrii 2020; 15(2): 7–20. (in Russ.) DOI:10,20953/1817–7646–2020–2–7–20
42. Geppe N.A., Afanasyeva O.I., Zaplatnikov A.L., Kondyurina E.G. Coronavirus infection in children. Voprosy prakticheskoy pediatrii 2020; 15(5): 73–86. (in Russ.) DOI: 10,20953/1817–7646–2020–5–73–86
43. Götzinger F., Santiago-García B., Noguera-Julián A., Lanaspa M., Lancella L., Carducci F.I.C. et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health 2020; 4: 653–661. DOI: 10,1016/S2352–4642(20)30177–2
44. Groß S., Jahn Ch. Cushman S., Bär Ch., Thum Th. SARSCoV- 2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications. J Mol Cel Cardiol 2020; 144: 47–53. DOI: 10,1016/j.yjmcc.2020.04.031
45. Diez J.-M., Romero C., Gajardo R. Currently available intravenous immunoglobulin (GamunexR-C and Flebogamma R DIF) contains antibodies reacting against SARS-CoV-2 antigens. BioRxiv 2020: 029017. DOI: 10,1101/2020.04.07,029017
46. Klimov Yu.A., Tikhonov S.V., Lalabekova M.V., Batysheva T.T., Aksenova E.I., Bykova O.V. et al. Medical rehabilitation of children who have undergone COVID-19 in the mode of a remote day hospital using digital technologies: temporary methodological guide No. 71. M.: Moscow Department of Health, 2020: 40. (in Russ.)
47. Ministry of Health of the Russian Federation. Methodical recommendations: Features of clinical manifestations and treatment of a disease caused by a new coronavirus infection (COVID-19) in children. Version 2 (07/03/2020). (in Russ.) https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_дети_COVID-19_v2.pdf/ Ссылка активна на 25.02.2022.
Review
For citations:
Kharitonova L.A., Grigoriev K.I. COVID-19: Lessons from pediatric science and practice. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2022;67(2):142-152. (In Russ.) https://doi.org/10.21508/1027-4065-2022-67-2-142-152